Expression of E-cadherin and vimentin in oral squamous cell carcinoma |
| |
Authors: | Jingping Zhou Detao Tao Qing Xu Zhenlin Gao Daofang Tang |
| |
Institution: | 1School of Stomatology, Wannan Medical College, Wuhu 241002, Anhui, China;2Department of Oral and Maxillofacial Surgery, Yijishan Hospital of Wannan Medical College, Wuhu 241001, Anhui, China;3Department of Oncology IV, First Hospital of Shijiazhuang, Shijiazhuang, 050011, Hebei, China |
| |
Abstract: | The aim of the study is to determine the levels of E-cadherin, vimentin expression in tumor tissues from patients with oral squamous cell carcinoma (OSCC), and the relationship between the expression of E-cadherin, vimentin and epithelial-mesenchymal transition, in order to explore its values for predicting the invasion and metastasis of oral squamous cell carcinoma, short survival of patients in many types of cancer. E-cadherin and vimentin expression of 10 benign and 42 OSCC tumor tissues was examined by immunohistochemical staining. E-cadherin is positively expressed in normal oral mucosa epithelium, but vimentin expression is not found in normal oral mucosa epithelia; the E-cadherin and vimentin were expressed in 26 of 42 (61.9%) and 16 of 42 (38.1%), respectively. No statistically difference was found for E-cadherin and vimentin expression in patients with different age, gender and tumor location, E-cadherin and vimentin expression was significantly associated with lymph node metastasis and tissue location (P < 0.05); E-cadherin expression was also significantly associated with tumor stage (P < 0.05); there are significantly difference between infiltrative margin and central area in patients with oral squamous cell carcinoma for E-cadherin and vimentin positive expression (P < 0.05). E-cadherin and vimentin positive expression was associated with tumor metastasis of oral squamous cell carcinoma. Our study preliminarily confirmed that EMT phenomenon is existed during the development of oral squamous cell carcinoma. Co-evaluation of E-cadherin and vimentin might be a valuable tool for predicting OSCC patient outcome. |
| |
Keywords: | Oral squamous cell carcinoma immunohistochemistry E-cadherin vimentin epithelial-mesenchymal transition |
|
|